National Cancer Institute - NCI Division of Cancer Treatment and ...

More documents

Recommendations

Info

Cancer Therapy Evaluation Program Office of the Associate Director Dr. Michaele Christian Associate Director Ms. Mary Louden Secretary Mr. Steven Friedman Protocol and Information Specialist Dr. Michael Montello Pharmacist Mr. George Redmond Informatician Ms. Ann Setser Nurse Consultant Ms. Denise Crute CTEP Protocol and Information Operation and Support [Contractor] Ms. Rachel Kidwiler CTEP Informatics and Computer Support [Contractor] Mr. Robert Miller Storage and Distribution of Clinical Agents [Contractor] Mr. Kamal Nurang Central Institutional Review Board (CIRB) Initiative [Contractor] Clinical Grants and Contracts Branch Dr. Roy Wu Branch Chief Dr. Kishor Bhatia Director, Office of AIDS Malignancy Program Dr. Claudio Dansky Ullmann Health Scientist Administrator Dr. Geraldina Dominguez Health Scientist Administrator, Office of AIDS Malignancy Program Ms. Denise Jenkins Program Specialist Ms. Elise Kreiss Program Specialist Dr. William Merritt Health Scientist Administrator Ms. Rolanda Wade Ricks Extramural Program Specialist Ms. Kim Witherspoon Biologist Dr. Heng Xie Medical Officer Clinical Investigations Branch Dr. Jeffrey Abrams Branch Chief Ms. Jeanne Adler Nurse Consultant Dr. Barry Anderson Medical Officer Ms. Andrea Denicoff Nurse Consultant Ms. Jacquelyn Goldberg Review Board Administrator Dr. Alison Martin Expert Dr. Margaret Mooney Expert Dr. Malcolm Smith Section Head Dr. Edward Trimble Medical Officer Dr. Jo Anne Zujewski Senior Disciplinary Scientist Mr. Stephen Riordan Cancer Trials Support Unit (CTSU) [Contractor] Ms. Claudine Valmonte Clinical Trials and Information Management Support [Contractor] D C T D R O S T E R ■ 133
Cancer Therapy Evaluation Program, continued 134 ■ P R O G R A M A C C O M P L I S H M E N T S 2 0 0 6 Clinical Trials Monitoring Branch Ms. Joan Mauer Branch Chief Ms. Rocio Paul Clinical Trials Monitoring Specialist Mr. Gary Lee Smith Clinical Trials Monitoring Specialist Ms. Jeanette Tomaszewski Clinical Trials Monitoring Specialist Ms. Nelly Villacreses Clinical Trials Monitoring Specialist Investigational Drug Branch Dr. James Zwiebel Acting Branch Chief Dr. Alice Chen Medical Officer Dr. Helen Chen Medical Officer Dr. Alexander Colevas Medical Officer Dr. Janet Dancey Senior Disciplinary Scientist Dr. S. Percy Ivy Medical Officer Dr. Jennifer Low Medical Officer Dr. Howard Streicher Medical Officer Dr. John Wright Medical Officer Pharmaceutical Management Branch Mr. Charles Hall, Jr. Branch Chief Mr. Matthew Boron Pharmacist Ms. Michele Eby Pharmacist Dr. Cheryl Grandinetti Pharmacist Mr. Rodney Howells Pharmacist Dr. Ravie Kem Pharmacist Ms. Patricia Schettino Supervisory Pharmacist Dr. Donna Shriner Senior Clinical Research Pharmacist Ms. Jeannette Wick Senior Clinical Research Pharmacist Ms. Tonisia Waymer Regulatory Affairs Branch Pharmaceutical Management Branch Support Services [Contractor] Dr. D. Dale Shoemaker Branch Chief Dr. Sherry Ansher Health Scientist Administrator Dr. Jan Casadei Chemist Ms. Sally Hausman Microbiologist Dr. Carolyn Laurencot Pharmacologist Dr. Rohini Misra Biologist Dr. Julie Rhie Pharmacologist Dr. Jennifer Wong Biologist Dr. Wendy Taddei-Peters CTEP Drug Development Support [Contractor]
Page 1 and 2:
National Cancer Institute U.S. DEPA
Page 3 and 4:
ii ■ P R O G R A M A C C O M P L
Page 5 and 6:
Clinical trials performed using an
Page 7 and 8:
Dr. James H. Doroshow, Director Jam
Page 9 and 10:
Cancer Diagnosis Program Dr. Sheila
Page 11 and 12:
DCTD Research Grants 6 ■ P R O G
Page 13 and 14:
disease-specific steering committee
Page 15 and 16:
■ The DCTD Developmental Therapeu
Page 17 and 18:
P A R T N E R S H I P S A N D C O L
Page 19 and 20:
laboratories. Dr. Kevin Dobbin, BRB
Page 21 and 22:
■ Gene expression patterns and pr
Page 23 and 24:
Simon R. DNA microarrays for diagno
Page 25 and 26:
Microarray Myths and Truths Myths
Page 27 and 28:
target, is sensitive to the agent.
Page 29 and 30:
O T H E R B I O S T A T I S T I C A
Page 31 and 32:
almost inevitably leads to an invas
Page 33 and 34:
Software and Technical Report Archi
Page 35 and 36:
Biomarker Development Process Marke
Page 37 and 38:
Strategic Partnering to Evaluate Ca
Page 39 and 40:
C U R R E N T F U N D I N G O P P O
Page 41 and 42:
P A R T N E R S H I P S A N D C O L
Page 43 and 44:
several types of cancer TMAs have b
Page 45 and 46:
Courtesy of NCI Visuals Online, Bil
Page 47 and 48:
■ Cooperative Human Tissue Networ
Page 49 and 50:
Progress in many areas of cancer re
Page 51 and 52:
Diagnostic Imaging Program in 1996,
Page 53 and 54:
NCI Visuals Online, Terese Winslow,
Page 55 and 56:
■ Support development and deliver
Page 57 and 58:
Small Animal Imaging Resource Progr
Page 59 and 60:
C U R R E N T F U N D I N G O P P O
Page 61 and 62:
Quick-Trials for Imaging and Image-
Page 63 and 64:
Association of American Cancer Inst
Page 65 and 66:
Food and Drug Administration and Ce
Page 67 and 68:
Dr. Edward A. Neuwelt, Oregon Healt
Page 69 and 70:
Virtual Colonoscopy Training Collec
Page 71 and 72:
Not only does CTEP identify promisi
Page 73 and 74:
The Clinical Trials Cooperative Gro
Page 75 and 76:
of pediatric cancers and therapeuti
Page 77 and 78:
the front line treatment of chronic
Page 79 and 80:
Quick-Trials for Novel Cancer Thera
Page 81 and 82:
Industry Collaborators Agent Name 7
Page 83 and 84:
Industry Collaborators Agent Name 7
Page 85 and 86:
NCI Visuals Online, George McGregor
Page 87 and 88: provided for use in this clinical t
Page 89 and 90: with or without bevacizumab (NSC #
Page 91 and 92: Oxaliplatin-Based Regimen Permits S
Page 93 and 94: egular checkups to look for lymph-n
Page 95 and 96: NCI Visuals Online. Human lymphoma
Page 97 and 98: T O O L S , P R O D U C T S , A N D
Page 99 and 100: ■ Clinical Trials Monitoring Bran
Page 101 and 102: DTP’s staff and administered gran
Page 103 and 104: therapeutics. Proposed exploratory
Page 105 and 106: M A J O R O N G O I N G I N I T I A
Page 107 and 108: National Cancer Institute. discover
Page 109 and 110: C U R R E N T F U N D I N G O P P O
Page 111 and 112: DTP oversees animal-production faci
Page 113 and 114: disease can require considerable in
Page 115 and 116: National Cancer Institute. commerci
Page 117 and 118: The Type 1 Diabetes Rapid Access to
Page 119 and 120: H I S T O R Y - M A R K I N G E V E
Page 121 and 122: With this approach, patients are no
Page 123 and 124: This included a camptothecin deriva
Page 125 and 126: RRP supports research involving a v
Page 127 and 128: Laredo Medical Center, Laredo, TX h
Page 129 and 130: With TELESYNERGY® as a link, healt
Page 131 and 132: Radiation Bioterrorism Research and
Page 133 and 134: Enhanced Radiosensitivity The Molec
Page 135 and 136: M E E T I N G S A N D W O R K S H O
Page 137: Cancer Imaging Program 132 ■ P R
Page 141 and 142: Developmental Therapeutics Program,
Page 143 and 144: Developmental Therapeutics Program,
show all

National Cancer Institute - NCI Division of Cancer Treatment and ...

Create successful ePaper yourself

Delete template?

Save as template?